Ferroptosis inducers |
Sulphasalazine |
System Xc−
|
Cysteine deprivation |
Gout et al. (2001)
|
Sorafenib |
System Xc−
|
Cysteine deprivation |
Louandre et al. (2013); Louandre et al. (2015)
|
Erastin |
System Xc−, VDAC2/3 |
Cysteine deprivation |
Dolma et al. (2003); Yagoda et al. (2007)
|
RSL3 |
GPX4 |
GPX4 inactivation and GSH deletion |
Yang et al. (2014)
|
ML162 |
GPX4 |
GPX4 inactivation and GSH deletion |
Moosmayer et al. (2021)
|
FINO2
|
GPX4 |
GPX4 inactivation and lipid peroxides accumulation |
Gaschler et al. (2018)
|
FIN56 |
CoQ10 and GPX4 |
CoQ10 deletion and GPX4 inactivation |
Shimada et al. (2016)
|
BSO |
GHS |
GHS deletion |
Yang et al. (2014)
|
DPI2 |
GSH |
GHS deletion |
Yang et al. (2014)
|
Cisplatin |
GSH |
Decreased GSH levels and GPX4 inactivation |
Yamaguchi et al. (2013)
|
Statins |
HMG |
CoQ10 deletion |
Chen et al. (2021b)
|
Siramesine |
Ferroportin |
Increased cellular iron |
Ma et al. (2016)
|
lapatinib |
Transferrin |
Increased cellular iron |
Ma et al. (2016)
|
Ferroptosis inhibitors |
Ferrostatin-1 |
ROS from lipid peroxidation |
Inhibition of lipid peroxidation |
Skouta et al. (2014)
|
Liproxstatin-1 |
ROS from lipid peroxidation |
Inhibition of lipid peroxidation |
Friedmann Angeli et al. (2014)
|
Vitamin E |
ROS from lipid peroxidation |
Inhibition of lipid peroxidation |
Hinman et al. (2018)
|
SRS 16–86 |
ROS from lipid peroxidation |
Inhibition of lipid peroxidation |
Linkermann et al. (2014a)
|
SRS 11–92 |
ROS from lipid peroxidation |
Inhibition of lipid peroxidation |
Skouta et al. (2014)
|
TEMPO |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Griesser et al. (2018)
|
PMC |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Shah et al. (2017)
|
Tetrahydronapthy-ridinols |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Angeli et al. (2017)
|
Phenothiazine |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Shah et al. (2017)
|
Phenoxazine |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Shah et al. (2017)
|
Diarylamine |
Radical-trapping antioxidant |
Elimination of oxygen free radicals |
Shah et al. (2017)
|
XJB-5-131 |
Nitroxide antioxidant |
Elimination of nitrogen oxides |
Krainz et al. (2016)
|
Baicalein |
Lipoxygenases |
Inactivation of lipoxygenase |
Yang and Stockwell, (2016)
|
BW A4C |
Lipoxygenases |
Inactivation of lipoxygenase |
Angeli et al. (2017)
|
AA-861 |
Lipoxygenases |
Inactivation of lipoxygenase |
Yang and Stockwell, (2016)
|
CDC |
Lipoxygenases |
Inactivation of lipoxygenase |
Yang and Stockwell, (2016)
|
PD146176 |
Lipoxygenases |
Inactivation of lipoxygenase |
Yang and Stockwell, (2016)
|
NDGA |
Lipoxygenases |
Inactivation of lipoxygenase |
Probst et al. (2017)
|
Zileuton |
Lipoxygenases |
Inactivation of lipoxygenase |
Yang and Stockwell, (2016)
|
Ciclopirox olamine |
Intracellular iron |
Decreased cellular iron |
Dixon et al. (2012)
|
2,2′-bipyridyl |
Intracellular iron |
Decreased cellular iron |
Dixon et al. (2012)
|
Deferoxamine mesylate |
Intracellular iron |
Decreased cellular iron |
Yang and Stockwell, (2008)
|
Deferoxamine |
Intracellular iron |
Decreased cellular iron |
Dixon et al. (2012)
|